Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The effects of the digital therapeutic Sleepio (a digital sleep programme) may extend to depressive symptoms, according to new research published in the Journal of Sleep Research.

A man with tired eyes laying down in bed with an alarm clock blurred in the image.

In the largest ever study examining the effects of a fully-automated digital sleep improvement programme based on cognitive behavioural techniques (Sleepio) on insomnia and depressive symptoms, researchers found that use of Sleepio improved not only insomnia symptoms, but also depressive symptoms in individuals with insomnia and clinically significant depressive symptoms. Further analyses revealed a significant proportion of the improvements in depressive symptoms were caused by the improvements in sleep.

The study included 3,352 participants and was a sub-analysis of data from two large effectiveness trials of Sleepio. The original trials investigated the effects of Sleepio on physical health and functioning and on mental health, respectively. In each case, study participants received digital cognitive behavioural therapy (CBT) using Big Health’s Sleepio programme.

Commenting on the findings, lead researcher and Research Manager at Big Health, Dr Alasdair Henry, said:

“Our study suggests that evidence-based digital therapeutics for sleep could be a powerful way to help millions of people not just sleep better, but also improve their depressive symptoms.

"In clinical studies, Sleepio has repeatedly achieved statistically significant and clinically meaningful improvements in sleep and mental health. Our latest results indicate that Sleepio can be an effective way to help those experiencing insomnia and clinically significant depressive symptoms achieve better outcomes over the long term through evidence-based cognitive and behavioural techniques.”

Professor of Clinical Psychology at the University of Oxford, Daniel Freeman, added:

“Depressive symptoms can be associated with significant stigma, which can prevent people from seeking help. These results show that addressing sleep may be an effective option for improving depressive symptoms, potentially providing a less stigmatized route to addressing broader mental health.

“Digital programmes like Sleepio overcome many of the barriers associated with accessing other forms of evidence-based care and it certainly increases people’s options. It could help in filling the enormous gap that currently exists in access to mental health care around the globe, and is particularly urgent during the current pandemic, when even access to routine care is disrupted.”

To read the full paper, Insomnia as a mediating therapeutic target for depressive symptoms: A sub-analysis of participant data from two large randomized controlled trials of a digital sleep intervention.

To read the full press release.

 

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Mitigating Impacts of COVID-19 Pandemic on Parents and Carers During School Closures

The International Public Policy Observatory's (IPPO) Rapid Evidence Review has now been released. Co-authored by Professor Cathy Creswell, the Review was commissioned by the UK Department for Education following a recommendation from the Scientific Advisory Group for Emergencies (SAGE).

Improved Risk Estimation of Bipolar Spectrum Disorders in Adolescent Offspring of Bipolar Parents

This new study using Canadian and Swiss data showed that the risk calculator used to predict the likelihood of developing a major mood disorder was correct approximately 70% of the time. The study results suggest this may be a useful clinical tool in routine practice for improved individualised risk estimation of bipolar spectrum disorders among the adolescent offspring of a parent with a bipolar disorder.

Impact of COVID-19 Partial School Closures and Mental Health

New research found that secondary school students with access to on-site school provision were more likely to report symptoms of depression and anxiety, as well as perceiving their mental wellbeing to have deteriorated during the first national lockdown, compared to students receiving remote school provision. Importantly, the poorer mental health for the group accessing school was explained by their different backgrounds and certain risk factors, such as past mental health needs and upcoming examinations.

Effect of the COVID-19 Pandemic on Eating Disorders

Using the electronic health records of over 5 million people aged under 30, researchers in the Oxford University Department of Psychiatry found that eating disorders were diagnosed significantly more commonly in 2020 than in previous years, with the rate increasing steadily throughout the year.

The Mental Health Impacts of Being an Olympian

The athletes competing in the Olympics mount a tremendous responsibility on their shoulders. Representing the pinnacle of human performance, Olympians are not merely idolized for their athletic abilities, but also often praised for their moral character, sportsmanship, and/or mental resilience.

Helping People with Psychosis Feel Less Distressed May Help Reduce the Risk of Self-harm

New research shows that by lessening the severity and impact of persecutory symptoms of psychosis, it may be possible to reduce the likelihood of someone with psychosis having thoughts of suicide or harming themselves.